Data / Form D filings / SPRUCE BIOSCIENCES, INC.
SPRUCE BIOSCIENCES, INC.: Form D filings
SPRUCE BIOSCIENCES, INC., a biotechnology company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on October 17, 2025, reports $50 million sold of a $50 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 611 GATEWAY BOULEVARD, SUITE 740, South San Francisco, CA, 94080
- Phone
- (415) 655-4168
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1683553
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | New notice | $49,999,768 | $49,999,768 | 21 | Oct 9, 2025 | sec.gov | |
| Feb 28, 2023 | New notice | $53,615,720 | $53,615,720 | 20 | Feb 16, 2023 | sec.gov | |
| Aug 14, 2020 | Amendment | $88,000,000 | $88,000,000 | 11 | Feb 19, 2020 | sec.gov | |
| Feb 28, 2020 | New notice | $88,000,000 | $44,000,000 | $44,000,000 | 11 | Feb 19, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kirk Ways | Director | |
| Javier Szwarcberg | Executive Officer, Director | |
| Simpson Camilla | Director | |
| Percival Barretto-Ko | Director | |
| Tiba Aynechi | Director | |
| Samir Gharib | Executive Officer | |
| Bali Muralidhar | Director | |
| Michael Grey | Executive Officer, Director | |
| Daniel Spiegelman | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SPRUCE BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.